← Back to search results

plannedFind a Tender · planning

Microbiology Serology Testing Managed Service

Buyer: NHS Blood and Transplant →

BuyerNHS Blood and Transplant
Statusplanned
DeadlineNot published
Value£50,000,000
Published21 Apr 2023

What is being bought

The purpose of this Prior Information Notice is to:<br/>• Alert potential suppliers that NHS Blood and Transplant intends to let a managed service contract which supports the delivery of Microbiology Serological screening/ testing of blood and non-blood donations. NOTE: The estimated total value below is based on a maximum 10-year contract duration.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support and innovation.<br/>• Make potential suppliers aware of the Kit Evaluation Group (KEG) and their assessment process for assays<br/><br/>An expression of interest must be e-mailed to Daniel.Kirkbride@nhsbt.nhs.uk by no later than Monday 29 May 2023, which includes the following:<br/>• Company Name and Address<br/>• Company point of contact details (Name, role, email and contact number)<br/>• Copies of the relevant assay Instructions for Use<br/><br/>Upon expressing an interest, potential suppliers will be sent a further request for information, to aid discussions at supplier engagement events to be arranged for June 2023. The formal publication of the procurement is planned for August/ September 2023.

Delivery location

UK

Categories

Diagnostic devices 33124100Diagnostic systems 33124110Diagnostic supplies 33124130Immuno-analysis devices 33127000Medical consumables 33140000Diagnostic kits 33141625Miscellaneous medical devices and products 33190000Blood-testing reagents 33696200Laboratory reagents 33696500Laboratory services 71900000Laboratory services 71900000

Lot details

Lot 1

NHSBT undertakes Microbiology Serology testing across three testing sites, the largest being Manchester and Filton testing laboratories. These test approximately 1.7 million donations per annum, which includes tests on blood, tissue and stem cell donations.<br/><br/>The third site, Microbiology Services Laboratory (MSL) in Colindale, tests approximately 5k donations per annum. MSL tests non-blood donations (tissue and stem cell), including those from deceased (not heart beating) tissue donors as well as undertaking confirmatory testing of screen reactive blood donations<br/><br/>Donation testing laboratories in Manchester and Filton perform the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B core (anti-HBc) **<br/>· Hepatitis B antibody (anti-HBs) ***<br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) **<br/>· Trypanosome cruzi (anti-T. cruzi) **<br/><br/>The Microbiology Services Laboratory (MSL) in Colindale performs the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B antibodies (anti-HBc) ** <br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) ** <br/>· Trypanosome cruzi (anti-T. cruzi) **<br/>· Cytomegalovirus (CMV) IgM ***<br/>· Hepatitis B antibodies (anti-HBs) ***<br/>* Mandatory requirement<br/>** On selected donations<br/>*** Where required<br/><br/>Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and therefore the assays used in MSL must be suitable for deceased donor screening.<br/><br/>Automated instrumentation is required to enable high throughput testing of mandatory and additional testing for blood and non-blood donors. Archiving and long-term storage of plasma samples is also required. Consideration will be given to all efficiency and innovation opportunities, including, but not limited to, middleware and sample presentation technology.<br/><br/>The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT systems without the need for development to NHSBT host IT systems.<br/><br/>All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (www.transfusionguidelines.org/red-book). <br/><br/>In accordance with the Guidelines for the Blood Transfusion service in the United Kingdom, Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of contract. The submission of your assay Instructions for Use will allow a desktop review of high-level mandatory requirements. If the high-level mandatory requirements are met during the desktop review, organisations will be invited to participate in the KEG process and be asked to formally submit FRM51 “Application for NHSBT Evaluation of Microbiology Test Kit”, a copy of which will supplied by NHSBT following a successful desktop review.<br/><br/>All in-vitro diagnostic medical devices, for example: instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2024 and from 01 July 2024 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended.

Statusplanned

What is included

ItemCategoryQuantity
1Miscellaneous medical devices and products, Diagnostic devices, Diagnostic kits, Diagnostic systems, Blood-testing reagents, Laboratory reagents, Laboratory services, Medical consumables, Immuno-analysis devices, Diagnostic suppliesNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Diagnostic devices (33124100); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,3333 median · 126.8 average (1,971 of 4,333 with a bid count)5.8 average (2,364 of 4,333 with named award suppliers)Not published
Same buyer711 median · 4.6 average (30 of 71 with a bid count)1.3 average (38 of 71 with named award suppliers)Not published
Delivery region: UK1,2079 median · 356.7 average (531 of 1,207 with a bid count)10.5 average (634 of 1,207 with named award suppliers)Not published
Similar published value (0.5×–2×)15794 median · 148 average (5 of 157 with a bid count)25 average (5 of 157 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-03c346
Latest release ID011542-2023
Latest release timestampFri Apr 21 2023 14:24:56 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanned
Procurement methodNot published
Procurement method detailsNot published
Main procurement categoryservices
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender value£50,000,000
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
21 Apr 2023planning011542-2023

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "011542-2023",
  "tag": [
    "planning"
  ],
  "date": "2023-04-21T15:24:56+01:00",
  "ocid": "ocds-h6vhtk-03c346",
  "buyer": {
    "id": "GB-FTS-18293",
    "name": "NHS Blood and Transplant"
  },
  "tender": {
    "id": "C166166 (Project Ref)",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHSBT undertakes Microbiology Serology testing across three testing sites, the largest being Manchester and Filton testing laboratories. These test approximately 1.7 million donations per annum, which includes tests on blood, tissue and stem cell donations.<br/><br/>The third site, Microbiology Services Laboratory (MSL) in Colindale, tests approximately 5k donations per annum. MSL tests non-blood donations (tissue and stem cell), including those from deceased (not heart beating) tissue donors as well as undertaking confirmatory testing of screen reactive blood donations<br/><br/>Donation testing laboratories in Manchester and Filton perform the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B core (anti-HBc) **<br/>· Hepatitis B antibody (anti-HBs) ***<br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) **<br/>· Trypanosome cruzi (anti-T. cruzi) **<br/><br/>The Microbiology Services Laboratory (MSL) in Colindale performs the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B antibodies (anti-HBc) ** <br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) ** <br/>· Trypanosome cruzi (anti-T. cruzi) **<br/>· Cytomegalovirus (CMV) IgM ***<br/>· Hepatitis B antibodies (anti-HBs) ***<br/>* Mandatory requirement<br/>** On selected donations<br/>*** Where required<br/><br/>Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and therefore the assays used in MSL must be suitable for deceased donor screening.<br/><br/>Automated instrumentation is required to enable high throughput testing of mandatory and additional testing for blood and non-blood donors. Archiving and long-term storage of plasma samples is also required. Consideration will be given to all efficiency and innovation opportunities, including, but not limited to, middleware and sample presentation technology.<br/><br/>The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT systems without the need for development to NHSBT host IT systems.<br/><br/>All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (www.transfusionguidelines.org/red-book). <br/><br/>In accordance with the Guidelines for the Blood Transfusion service in the United Kingdom, Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of contract. The submission of your assay Instructions for Use will allow a desktop review of high-level mandatory requirements. If the high-level mandatory requirements are met during the desktop review, organisations will be invited to participate in the KEG process and be asked to formally submit FRM51 “Application for NHSBT Evaluation of Microbiology Test Kit”, a copy of which will  supplied by NHSBT following a successful desktop review.<br/><br/>All in-vitro diagnostic medical devices, for example: instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2024 and from 01 July 2024 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "NHSBT Filton, 500 North Bristol Park Northway, Filton, Bristol BS34 7QH<br/>NHSBT Manchester, Plymouth Grove, Manchester M13 9LL<br/>NHSBT Colindale, Charcot Road, Colindale, London NW9 5BG"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33190000",
            "scheme": "CPV",
            "description": "Miscellaneous medical devices and products"
          },
          {
            "id": "33124100",
            "scheme": "CPV",
            "description": "Diagnostic devices"
          },
          {
            "id": "33141625",
            "scheme": "CPV",
            "description": "Diagnostic kits"
          },
          {
            "id": "33124110",
            "scheme": "CPV",
            "description": "Diagnostic systems"
          },
          {
            "id": "33696200",
            "scheme": "CPV",
            "description": "Blood-testing reagents"
          },
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "33140000",
            "scheme": "CPV",
            "description": "Medical consumables"
          },
          {
            "id": "33127000",
            "scheme": "CPV",
            "description": "Immuno-analysis devices"
          },
          {
            "id": "33124130",
            "scheme": "CPV",
            "description": "Diagnostic supplies"
          }
        ]
      }
    ],
    "title": "Microbiology Serology Testing Managed Service",
    "value": {
      "amount": 50000000,
      "currency": "GBP"
    },
    "status": "planned",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The purpose of this Prior Information Notice is to:<br/>• Alert potential suppliers that NHS Blood and Transplant intends to let a managed service contract which supports the delivery of Microbiology Serological screening/ testing of blood and non-blood donations. NOTE: The estimated total value below is based on a maximum 10-year contract duration.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support and innovation.<br/>• Make potential suppliers aware of the Kit Evaluation Group (KEG) and their assessment process for assays<br/><br/>An expression of interest must be e-mailed to Daniel.Kirkbride@nhsbt.nhs.uk by no later than Monday 29 May 2023, which includes the following:<br/>• Company Name and Address<br/>• Company point of contact details (Name, role, email and contact number)<br/>• Copies of the relevant assay Instructions for Use<br/><br/>Upon expressing an interest, potential suppliers will be sent a further request for information, to aid discussions at supplier engagement events to be arranged for June 2023. The formal publication of the procurement is planned for August/ September 2023.",
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome",
      "futureNoticeDate": "2023-08-31T00:00:00+01:00"
    },
    "classification": {
      "id": "71900000",
      "scheme": "CPV",
      "description": "Laboratory services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-18293",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "name": "Daniel Kirkbride",
        "email": "daniel.kirkbride@nhsbt.nhs.uk",
        "telephone": "+44 7764280366"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
21 Apr 2023 · 011542-2023 · planning
{
  "id": "011542-2023",
  "tag": [
    "planning"
  ],
  "date": "2023-04-21T15:24:56+01:00",
  "ocid": "ocds-h6vhtk-03c346",
  "buyer": {
    "id": "GB-FTS-18293",
    "name": "NHS Blood and Transplant"
  },
  "tender": {
    "id": "C166166 (Project Ref)",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHSBT undertakes Microbiology Serology testing across three testing sites, the largest being Manchester and Filton testing laboratories. These test approximately 1.7 million donations per annum, which includes tests on blood, tissue and stem cell donations.<br/><br/>The third site, Microbiology Services Laboratory (MSL) in Colindale, tests approximately 5k donations per annum. MSL tests non-blood donations (tissue and stem cell), including those from deceased (not heart beating) tissue donors as well as undertaking confirmatory testing of screen reactive blood donations<br/><br/>Donation testing laboratories in Manchester and Filton perform the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B core (anti-HBc) **<br/>· Hepatitis B antibody (anti-HBs) ***<br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) **<br/>· Trypanosome cruzi (anti-T. cruzi) **<br/><br/>The Microbiology Services Laboratory (MSL) in Colindale performs the following tests:<br/>· Hepatitis B (HBsAg) *<br/>· Hepatitis B antibodies (anti-HBc) ** <br/>· Human immunodeficiency virus (HIV 1&2 Ab/Ag) *<br/>· Hepatitis C (anti-HCV) *<br/>· Syphilis antibodies *<br/>· Human T-lymphotropic virus I/II (anti-HTLV) *<br/>· Cytomegalovirus (CMV) IgG or Total antibody **<br/>· Malarial antibody (anti-malaria) ** <br/>· Trypanosome cruzi (anti-T. cruzi) **<br/>· Cytomegalovirus (CMV) IgM ***<br/>· Hepatitis B antibodies (anti-HBs) ***<br/>* Mandatory requirement<br/>** On selected donations<br/>*** Where required<br/><br/>Deceased (non-heart beating) donor screening is performed at Microbiology Services Laboratory (MSL), Colindale and therefore the assays used in MSL must be suitable for deceased donor screening.<br/><br/>Automated instrumentation is required to enable high throughput testing of mandatory and additional testing for blood and non-blood donors. Archiving and long-term storage of plasma samples is also required. Consideration will be given to all efficiency and innovation opportunities, including, but not limited to, middleware and sample presentation technology.<br/><br/>The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT systems without the need for development to NHSBT host IT systems.<br/><br/>All Microbiology Serology testing requirements must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (www.transfusionguidelines.org/red-book). <br/><br/>In accordance with the Guidelines for the Blood Transfusion service in the United Kingdom, Kit Evaluation Group (KEG) approval of the assays must be obtained prior to the award of contract. The submission of your assay Instructions for Use will allow a desktop review of high-level mandatory requirements. If the high-level mandatory requirements are met during the desktop review, organisations will be invited to participate in the KEG process and be asked to formally submit FRM51 “Application for NHSBT Evaluation of Microbiology Test Kit”, a copy of which will  supplied by NHSBT following a successful desktop review.<br/><br/>All in-vitro diagnostic medical devices, for example: instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2024 and from 01 July 2024 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "NHSBT Filton, 500 North Bristol Park Northway, Filton, Bristol BS34 7QH<br/>NHSBT Manchester, Plymouth Grove, Manchester M13 9LL<br/>NHSBT Colindale, Charcot Road, Colindale, London NW9 5BG"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33190000",
            "scheme": "CPV",
            "description": "Miscellaneous medical devices and products"
          },
          {
            "id": "33124100",
            "scheme": "CPV",
            "description": "Diagnostic devices"
          },
          {
            "id": "33141625",
            "scheme": "CPV",
            "description": "Diagnostic kits"
          },
          {
            "id": "33124110",
            "scheme": "CPV",
            "description": "Diagnostic systems"
          },
          {
            "id": "33696200",
            "scheme": "CPV",
            "description": "Blood-testing reagents"
          },
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "33140000",
            "scheme": "CPV",
            "description": "Medical consumables"
          },
          {
            "id": "33127000",
            "scheme": "CPV",
            "description": "Immuno-analysis devices"
          },
          {
            "id": "33124130",
            "scheme": "CPV",
            "description": "Diagnostic supplies"
          }
        ]
      }
    ],
    "title": "Microbiology Serology Testing Managed Service",
    "value": {
      "amount": 50000000,
      "currency": "GBP"
    },
    "status": "planned",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The purpose of this Prior Information Notice is to:<br/>• Alert potential suppliers that NHS Blood and Transplant intends to let a managed service contract which supports the delivery of Microbiology Serological screening/ testing of blood and non-blood donations. NOTE: The estimated total value below is based on a maximum 10-year contract duration.<br/>• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support and innovation.<br/>• Make potential suppliers aware of the Kit Evaluation Group (KEG) and their assessment process for assays<br/><br/>An expression of interest must be e-mailed to Daniel.Kirkbride@nhsbt.nhs.uk by no later than Monday 29 May 2023, which includes the following:<br/>• Company Name and Address<br/>• Company point of contact details (Name, role, email and contact number)<br/>• Copies of the relevant assay Instructions for Use<br/><br/>Upon expressing an interest, potential suppliers will be sent a further request for information, to aid discussions at supplier engagement events to be arranged for June 2023. The formal publication of the procurement is planned for August/ September 2023.",
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome",
      "futureNoticeDate": "2023-08-31T00:00:00+01:00"
    },
    "classification": {
      "id": "71900000",
      "scheme": "CPV",
      "description": "Laboratory services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-18293",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "name": "Daniel Kirkbride",
        "email": "daniel.kirkbride@nhsbt.nhs.uk",
        "telephone": "+44 7764280366"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}